Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study

• Status: Terminated
• Trial end date: 2009-08-31
• Target enrollment: 0
• Participant gender: Female

Summary

ZPE-201 Extension of treatment

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Repros Therapeutics Inc.

Criteria

Inclusion Criteria:

• Only subjects treated in the ZPE-201 study will be allowed to enter the extension study.

• Subjects who withdrew from ZPE-201 due to lack of treatment efficacy will also be invited to participate.

Exclusion Criteria:

• All other subjects